The Eureka Machine: Richard Socher Breaks Down Science In The AI Age

Richard Socher’s The Eureka Machine argues agentic superintelligence could transform science through simulation, integration, ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Time

Inside the Race to Make AI Build Itself

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
InfoQ

MIT's Recursive Language Models Improve Performance on Long-Context Tasks

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Chad Schuster discusses bridging Python's ...
Monocle

The Stack

We speak with Grace O’Neill and Paulina Paige Ortega from the new title ‘Persona’. Plus: Simon Freeman on the expansion of ‘Like the Wind’ and Claire Belhassine from ‘Godmothers of AI’. We speak with ...
Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...